PHASE I CLINICAL TRIAL on the ACTIVITY of REALBUILD®

The ReaLBuild® Clinical Trial Phase I, conducted at Cancer Treatment Centers of America (CTCA) is now terminated. The CTCA team is very enthusiastic about the results, and a publication is forthcoming. A Phase II Protocol is now being discussed.

THE WORK OF DR. MIRKO BELJANSKI

Mirko Beljanski, PhD, spent the major portion of his professional life in the labs at the Pasteur Institute, France. He published 133 peer-reviewed research reports, many of which are available on-line at www.PubMed.gov.

For other publications not available on PubMed.gov, please refer to www.beljanski.com, dedicated to the work of Dr. Beljanski.

There have also been a number of educational books published relating to the work of Dr. Beljanski. These can be viewed at www.evibooks.com.